FTC to sue PBMs over drug prices including insulin, source says
WEBJul 10, 2024 · The Federal Trade Commission is planning to sue three large U.S. health companies over their practices as middlemen who negotiate prices for medications such as insulin, as the agency...
Feds poised to sue pharmacy gatekeepers over high drug costs
WEBJul 10, 2024 · The Federal Trade Commission is getting ready to sue big health care companies, claiming that they are illegally maximizing profits by steering patients to high-cost drugs, according to...
FTC Accuses Drug Managers Of Squeezing Patients And Pharmacies - Forbes
WEBJul 11, 2024 · The FTC blasted pharmacy benefit managers, accusing them of raising patients’ costs and driving pharmacies out of business. The FTC is planning to sue the 3 largest PBMs.
Exclusive | FTC to Sue Drug Managers Over Insulin Prices
WEBJul 10, 2024 · The Federal Trade Commission is preparing to sue the largest three pharmacy-benefit managers over their tactics for negotiating prices for drugs including insulin, after a two-year...
FTC Intends to Sue Biggest Pharmacy Benefit Managers for Unfair ...
WEBJul 11, 2024 · The Federal Trade Commission (FTC) is preparing to sue the 3 biggest pharmacy benefit managers (PBMs) for their role in negotiating unfair drug prices for patients and driving up the prices of key drugs like insulin, the details of which were released in an interim report by the Commission, according to multiple sources. 1-5.
FTC Will Sue Pharmacy Middlemen Over Inflated Drug Prices - Forbes
WEBJul 10, 2024 · The Federal Trade Commission will sue three of the largest pharmacy benefit managers after the agency released a report alleging the companies—which manage roughly 80% of prescriptions in...
F.T.C. Slams Middlemen for High Drug Prices - The New York Times
WEBJul 9, 2024 · The Federal Trade Commission on Tuesday sharply criticized pharmacy benefit managers, saying in a scathing 71-page report that “these powerful middlemen may be profiting by inflating drug costs...
US FTC to sue drug middlemen over insulin prices, source says
WEBJuly 10 (Reuters) - The U.S. Federal Trade Commission is planning to sue UnitedHealth (UNH.N), Cigna (CI.N) and CVS Health (CVS.N) over their tactics as middlemen in negotiating prices for drugs...
FTC poised to sue drug middlemen over insulin prices - Axios
WEBJul 11, 2024 · The Federal Trade Commission plans to sue the three biggest prescription drug middlemen for allegedly using negotiating tactics to steer patients to use more expensive drugs, including insulins, according to a source familiar with the matter.
FTC preparing suit against drug middlemen over insulin rebates
WEBJul 11, 2024 · The Federal Trade Commission is preparing a lawsuit against the three largest drug intermediaries over their use of rebates for insulin and other drugs, according to a person familiar with...
Skip to content